845 A colony stimulating factor 1 receptor-blocking bifunctional protein simultaneously targets tumor-associated macrophages and exhausted T cells for the treatment of triple-negative breast cancer

• Muh-Hwa Yang,
• Pandelakis Koni,
• Hung-Kai Chen,
• Yao-Wen Chang,
• Huey-Wen Hsiao,
• Chih-Lun Hsiao,
• Jing-Yi Huang,
• Ju-Pei Chen

Affiliations

Muh-Hwa Yang

Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan

Pandelakis Koni

1Elixiron Immunotherapeutics, Taipei City, Taiwan, Province of China

Hung-Kai Chen

1Elixiron Immunotherapeutics, Taipei City, Taiwan, Province of China

Yao-Wen Chang

2National Yang Ming Chiao Tung University, Taipei City, Taiwan, Province of China

Huey-Wen Hsiao

1Elixiron Immunotherapeutics, Taipei City, Taiwan, Province of China

Chih-Lun Hsiao

1Elixiron Immunotherapeutics, Taipei City, Taiwan, Province of China

Jing-Yi Huang

1Elixiron Immunotherapeutics, Taipei City, Taiwan, Province of China

Ju-Pei Chen

2National Yang Ming Chiao Tung University, Taipei City, Taiwan, Province of China